Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Paragon 28 Inc FNA

Paragon 28, Inc. is a medical device company focused on the foot and ankle orthopedic market. The Company provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful... see more

Recent & Breaking News (NYSE:FNA)

Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024

Business Wire April 4, 2024

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE(TM) Extraosseous Repair System

Business Wire March 28, 2024

Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance

Business Wire February 29, 2024

Paragon 28 to Present at the CG 2024 Musculoskeletal Conference

Business Wire February 12, 2024

Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Business Wire February 6, 2024

Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions

Business Wire February 1, 2024

Paragon 28 Announces the Launch of the FJ2000(TM) Power Console and Burr System Designed Specifically for Foot and Ankle Procedures

Business Wire January 30, 2024

Paragon 28 Launches the Mister Tendon(TM) Harvester System - The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures

Business Wire January 26, 2024

Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic(TM) - A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures

Business Wire January 17, 2024

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023

Business Wire January 8, 2024

Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline(TM) Tape

Business Wire January 5, 2024

Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire December 19, 2023

Paragon 28 Launches BEAST(TM) Cortical Fibers Expanding its Biologics Portfolio

Business Wire November 14, 2023

Paragon 28 Launches JAWS(TM) Great White Staple System Further Expanding its Nitinol Staple Offering

Business Wire November 14, 2023

Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program

Business Wire November 13, 2023

Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

Business Wire November 7, 2023

Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility

Business Wire November 7, 2023

Paragon 28 to Present at Upcoming Investor Conferences

Business Wire November 3, 2023

Paragon 28 To Report Third Quarter Financial Results on November 7, 2023

Business Wire October 17, 2023

Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus(TM) System for use in Conjunction with the APEX 3D(TM) Total Ankle Replacement System

Business Wire September 11, 2023